Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's escitalopram
oxalate 20 mg tablets to Forest's Lexapro® 20 mg tablets following a single, oral 20 mg (1 x
20 mg) dose administered under fed conditions.